Evaluation of the effect of saffron oral capsules on pain severity and duration of the active phase of labor first stage

Research Council of Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Completing the written informed consent to participate in the study?age of 18-35 years; body mass index of 19.5- 30;gestational age of 37-42 weeks; having no history of pregnancy more than 20 weeks of gestation; singleton pregnancy; cervical dilatation of 3-4 cm; cephalic presentation.
•Exclusion criteria:
•using any herbal drug during the past 48 hours; addiction or using a variety of tobacco and alcohol; maternal pregnancy complications (preeclampsia, bleeding during pregnancy, threat to abortion, premature rupture of fetus membranes more than 12 hours before admission of mother), having or history of any systemic disease (diabetes, hypertension, heart and kidney disease, etc), history of mental disorder, speaking, hearing and mental disorder, disproportion of maternal pelvic with fetal head; estimated fetal weight less than 2500 g and more than 4000 g (according to Johnson rules); fetal heart rate abnormalities; any abnormalities in the fetus (based on sonography; obstetric problems; multiple pregnancy; previous surgery on the uterus; cervix and delivery canal; cesarean indication; allergic reaction to the saffron

发起方

Research Council of Mashhad University of Medical Sciences